Darunavir

Details

Files

Generic Name:

Darunavir

Project Status:

Complete

Therapeutic Area:

HIV infection (Pediatric)

Manufacturer:

Janssen-Ortho Inc.

Brand Name:

Prezista

Project Line:

Reimbursement Review

Project Number:

SR0194-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

HIV infection (Pediatric)

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

June 17, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : December 22, 2009